...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM Oct 26, 2023

"or even a 2024 IPO,"

I'm all for that.

Ticker symbol "ZEN", right out, on the Nasdaq Exchange.

 

Koo

Share
New Message
Please login to post a reply